Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients-Reference-Cited by-同舟云学术

Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients

Published:2015-07-01 Issue:3 Volume:69 Page:312-318
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Lapadula Giuseppe,Costarelli Silvia,Chatenoud Liliane,Castelli Francesco,Astuti Noemi,Di Giambenedetto Simona,Quiros-Roldan Eugenia,Sighinolfi Laura,Ladisa Nicoletta,Di Pietro Massimo,Zoncada Alessia,Di Filippo Elisa,Gori Andrea,Nasta Paola,Torti Carlo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference31 articles.

1. . Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.;Sulkowski;JAMA,2000

2. . Risk factors for hepatotoxicity in patients treated with highly active antiretroviral therapy.;Bonfanti;J Acquir Immune Defic Syndr,2001

3. . Hepatic profile analyses of tipranavir in Phase II and III clinical trials.;Mikl;BMC Infect Dis,2009

4. . Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999).;Servoss;J Acquir Immune Defic Syndr,2006

5. . Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy.;Wit;J Infect Dis,2002

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Liver Enzyme Elevation and Use of Contemporary ARVs Among People With HIV;Open Forum Infectious Diseases;2024-06

2. Hepatic Toxicity Assessment in HIV’s Interaction with Reverse Transcriptase and Integrase Strand Transfer Inhibitors at a Military Hospital, Southsouth Nigeria;2024-05-01

3. LIVER FUNCTION IN A COHORT OF YOUNG HIV-HBV CO-INFECTED PATIENTS ON LONG-TERM COMBINED ANTIRETROVIRAL THERAPY;FARMACIA;2020-02-25

4. Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort;Journal of Antimicrobial Chemotherapy;2019-08-27

5. Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study;European Journal of Clinical Microbiology & Infectious Diseases;2018-01-09